Magnetic Levitation Technology, called Bivacor, is the 1st Success Case with Non-Natural Body in the country
An Australian man became the 1st in the world to receive hospital discharge with a total artificial heart, after living more than 100 days with the device. The patient was released on Tuesday (11.mar.2025) in Sydney, in the state of Nova Gales do Sul.
O, called Bivacor, represents an advance in the treatment of terminal internship biventricular heart failure. Developed by an Australian team, the device uses magnetic levitation technology to simulate the blood flow of a healthy heart.
Bivacor is intended for patients whose hearts cannot effectively pump blood due to damage caused by diseases such as heart attacks and coronary artery disease. The Australian government supported the project with 50 million Australian dollars.
The goal is to benefit more than 23 million people affected by heart failure annually worldwide. Currently, only 6,000 of these patients can receive a donor heart each year.
The patient, who preferred to maintain his identity confidential, was the 1st in Australia and the 6th globally receiving Bivacor. The surgery was held on November 22 at St Vincent’s Hospital in Sydney.
After a period in the Intensive Care Unit, the patient was discharged in February, and a donor heart became available to him in March. Despite its success, the artificial heart is not yet considered a definitive substitute for heart transplantation due to the difference in the duration of operation between the device and a donor heart.
